BLUE-OCEAN-ROBOTICS
15.6.2020 15:04:13 CEST | Business Wire | Press release
Blue Ocean Robotics announced it has been included in Robotics Business Review’s list of the 50 most influential robotics companies in the world (RBR50 ) for its UVD Robots . The recognition was earned for work with UVD Robot, the health benefits of its technology and the continued growing demand for its disinfecting capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200615005041/en/
UVD Robots combines deep microbiological know-how, autonomous robot technology and ultraviolet light to create the world’s best UV-C based disinfection solution, proven to eliminate pathogens within 10-15 minutes in a room. The robots have been rolled out to more than 60 countries worldwide.
“UVD Robots has more than 75% of the world market of autonomous mobile UV-C disinfection robots,” says Claus Risager, CEO at Blue Ocean Robotics. “With the anticipated future growth, our 2-4 year lead on competitors with patented solutions, we are the dominant player for the future.”
Founded through a collaboration with Odense University Hospital, Blue Ocean Robotics created UVD Robots as a subsidiary in 2014 to solve the problem of Hospital Acquired Infections (HAI). One in fifteen people get infected in hospitals.
Eugene Demaitre, senior editor at The Robot Report and Robotics Business Review, said, “The solution was introduced to the market even before the COVID-19 pandemic, and since then UVD Robots has been able to scale its production to the growing global demand for automated disinfection. We expect that the Danish RBR50 company will, in the future, help both hospitals and other localities prevent infections as well.”
About Blue Ocean Robotics
Blue Ocean Robotics
develops, produces and sells professional service robots in healthcare, hospitality, construction, agriculture, and other global markets. The portfolio of robots includes brands; UVD Robots
, a mobile robot for disinfection; GoBe Robots
, a mobile telepresence robot for communication, social inclusion, and CO2 climate improvements; and PTR Robots
, a mobile robot for safe patient handling and rehabilitation. Blue Ocean Robotics develops the robots from problem and idea all the way to scale up. Each robot is placed in its own subsidiary-venture company, making Blue Ocean Robotics the world’s first Robot Venture Factory.
Download the press kit here
View source version on businesswire.com: https://www.businesswire.com/news/home/20200615005041/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Return Abuse Goes Mainstream as Nearly Half of Consumers Use AI in Return Claims, New Riskified Research Finds22.6.2026 14:30:00 CEST | Press release
New global study shows normalization of strategic returns, widening regional differences, and rapid AI adoption reshaping ecommerce post-purchase risk Riskified (NYSE: RSKD), a global leader in ecommerce fraud detection and risk intelligence, today released a new global report, “Rewriting the Rules on Returns”, exploring how consumer attitudes and behaviors around ecommerce returns are evolving in the age of artificial intelligence (AI). The Riskified-commissioned study, conducted by eTail Insights, is based on a survey of 2,091 consumers across seven countries, alongside in-depth interviews with senior leaders from many of the largest retail companies in the world. The research finds that return abuse behaviors are increasingly normalized, while nearly half of consumers already use generative AI tools to assist with return or refund claims. At the same time, merchants are responding by tightening return policies, shortening return windows, and deploying advanced AI detection to better
Forrester Unveils Agendas For 2026 Technology & Innovation Forums In North America And EMEA22.6.2026 14:00:00 CEST | Press release
The Forums will equip technology leaders with the capabilities needed to operationalize AI and build high-performing IT organizations that deliver measurable business outcomes Forrester (Nasdaq: FORR) today announced the full conference agendas for its Technology & Innovation Forum Central (Austin, September 14–15, 2026), Technology & Innovation Forum EMEA (London, September 30–October 1, 2026), and Technology & Innovation Forum East (New York City, November 4–5, 2026). This year’s theme, “The IT Singularity,” dives into the new AI era in which AI has become ubiquitous and no longer a competitive advantage on its own. To succeed, technology leaders including chief information officers, chief data officers, and chief AI officers need to integrate AI into their operating models, modernize software development and IT operations, strengthen data and governance practices, and align technology investments with business strategy. Across the Forums, tech leaders and their teams will learn how
AdvanCell Establishes U.S. Global Headquarters and Secures Flagship Manufacturing Facility in Greater Boston to Drive Growth Strategy22.6.2026 14:00:00 CEST | Press release
New 128,000-square-foot facility in Andover will serve as U.S. global headquarters and future manufacturing center supporting the development and commercialization of ADVC001 and the Company’s pipeline of Lead-212 targeted alpha therapies Expanding U.S. operations complement the Company’s established Australian R&D and manufacturing capabilities to create a global, vertically integrated platform for radiopharmaceutical development and commercial supply AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the establishment of its U.S. Global Headquarters in the Greater Boston area, and the lease of a new 128,000-square-foot facility that will become the Company’s U.S. flagship manufacturing center supporting its long-term growth and commercialization strategy. The expansion marks an important milestone in the Company’s evolution into a U.S.-based radiopharmaceutical company with integrated operations spanning
Print Creates an Enterprise Dark Data Problem. VasionⓇ Innovated Again to Find the Solution.22.6.2026 14:00:00 CEST | Press release
Intelligent Print Automation Turns the File > Print Workflow Into an AI-Ready Data Pipeline Every time employees click File > Print to send documents to printers, save them to PDFs or scan them to unmanaged folders, enterprise data becomes unstructured and quietly goes dark. Dark data escapes compliance controls, bypasses AI workflow and quickly becomes a liability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260622562749/en/ Vasion is the Intelligent Print Automation leader making digital transformation attainable for all by eliminating print servers, consolidating print environments, digitizing and automating workflows. Gartner® reports that “roughly 80% of enterprise information is unstructured, spread across documents, files, and rich content in dozens of systems.” Gartner® also predicts that “by 2028, large enterprises will triple their unstructured data capacity across their on-premises, edge and public cloud locati
HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors22.6.2026 14:00:00 CEST | Press release
Values Company at $3.75 Billion and Funds Development of Additional Clinical Applications HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the closing of a new financing round with participation from Reed Jobs and Yosemite, whose aim is to “make cancer non-lethal in our lifetime,” alongside several new strategic investors. Additional financing terms were not disclosed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260622435314/en/ HistoSonics Edison® Histotripsy System The financing comes amid significant momentum for HistoSonics as the company continues to expand clinical adoption of histotripsy for liver tumors around the world and is quickly advancing additional applications of its non-invasive platform across solid tumors. "Building a generational company requires partners who bring more than capital,” commented Mike Blue, Chairman & CEO, HistoSonics.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom